Enliven Therapeutics Inc
(NAS:ELVN)
$
57.89
-0.84 (-1.43%)
Market Cap: 4.24 Bil
Enterprise Value: 3.35 Bil
PE Ratio: 0
PB Ratio: 4.28
GF Score: 31/100 Enliven Therapeutics Inc (ELVN) Transcripts
- 1